rs33935383
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM5PP3
The NM_000518.5(HBB):c.371C>T(p.Thr124Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,461,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T124N) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.371C>T | p.Thr124Ile | missense_variant | 3/3 | ENST00000335295.4 | NP_000509.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.371C>T | p.Thr124Ile | missense_variant | 3/3 | 1 | NM_000518.5 | ENSP00000333994 | P1 | |
HBB | ENST00000647020.1 | c.371C>T | p.Thr124Ile | missense_variant | 3/3 | ENSP00000494175 | P1 | |||
HBB | ENST00000475226.1 | n.303C>T | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
HBB | ENST00000633227.1 | c.*187C>T | 3_prime_UTR_variant, NMD_transcript_variant | 3/3 | 3 | ENSP00000488004 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251294Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135814
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461738Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727190
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Dec 19, 2016 | - - |
beta Thalassemia Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Mar 18, 2023 | The HBB c.371C>T (p.Thr124Ile) variant (also known as Hb Villejuif) is described as an asymptomatic variant in heterozygous carriers with normal stability. This silent variant was first reported in an individual who coincidentally had polycythemia vera with the red blood cells showing normal oxygen binding properties (PMID: 2816924 (1989)). Later, the variant was observed in a family who had normal hemoglobin analysis results with a slight increase in Hb A2 concentration (PMID: 11300351 (2001)). Based on the available information, we are unable to determine the clinical significance of this variant. - |
HEMOGLOBIN VILLEJUIF Other:1
other, no assertion criteria provided | literature only | OMIM | Dec 12, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at